AzTrials
AzTrials

PsychiatryAfter Pass'AjeNCT03309670

Psychiatric Future of Young Patients Hospitalized in the Pass'Aje Service Between 2006 and 2010

An observational study of Psychiatry, run by University Hospital, Clermont-Ferrand at 1 site in France.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The emergence of adult psychic disorders occurs in about three quarters of cases before 25 years. The Pass-Aje service of Clermont-Ferrand University Hospital is a psychiatric unit specializing in the management of disorders of young adults. Read more about this study

Who is it for?
Ages 23 to 36 years
Conditions the study is for
Psychiatry
What is being tested?
Psychiatric future
How many people
660 participants
Where
1 siteFrance
Study dates
14 Sep 2017to 15 May 2019
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 23 to 36 years
  • All sexes
  • No healthy volunteers
  • Adult

Study population: Young patients hospitalized in psychiatric service

Who may be able to join

  • all patients hospitalized in the Pass'Aje unit between 2006 and 2010
  • Aged from 16 to 25 years when hospitalized

Who cannot join

  • Patient refusing or not understanding the purpose of the study.
  • Patients who died.
  • Patient phone number unavailable or non-functional

Trial locations and contacts

1 site in 1 country.

France1 site, 1 recruiting
  • CHU Clermont-Ferrand

    Clermont-Ferrand, 63003

    Patrick LACARIN, 04 73 75 11 95, placarin@chu-clermontferrand.fr

    Eve COURTY

    Recruiting

Other trials in France

About this study

The emergence of adult psychic disorders occurs in about three quarters of cases before 25 years. The Pass-Aje service of Clermont-Ferrand University Hospital is a psychiatric unit specializing in the management of disorders of young adults. This unit evaluates the first episodes among the diversity of the clinical presentations of the psychic disorders. Suicidal attempts or ideations account for a large part of the reasons for entering the unit and are found transversely in many disorders. Among the reasons for hospitalization are a wide variety of situations that are not initially associated with an accurate diagnosis such as withdrawal, de-schooling, runaways, behavioral disorders (disorders of social interactions, self and hetero aggression, eating disorders).

Investigator propose to study the psychiatric outcome of hospitalized patients in the Pass-Aje unit and their psychosocial evolution in order to compare them with the data of the general population and to identify the factors influencing their future.

Read the detailed description

Former young psychiatric patients hospitalized in the Pass'Aje units are contacted by phone several years later to determine their psychiatric outcome.

Conditions
Psychiatry
Being tested
Psychiatric future
Keywords
psychiatric outcome, psychosocial outcome, young

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Psychiatric futureOther

    Former young psychiatric patients are contacted to determine their psychiatric outcome.

Study groups in NCT03309670
Study groupRoleWhat they receive
Formers young patientsall patients hospitalized between 2006 and 2010 in the Pass'Aje unit
Receives: Other: Psychiatric future

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Psychiatric rehospitalisation

    the psychiatric outcome comprises 3 parameters :

    • ongoing psychiatric follow-up (yes / no)
    • psychotropic treatment in progress (yes / no)
    • psychiatric hospitalizations after the first hospitalization in Pass'Aje (yes / no)

    Measured: at day 1 during the phone call

Secondary outcomes (2)
  1. Determination of social outcomes

    Educational level of obtained by patients will be compared to data of the general population according to sex, age and parents' social environment

    Measured: at day 1 during the phone call

  2. Percentage of patients with an occupational activity

    Percentage of patients with an occupational activity will be compared to data of the general population according to sex, age and parents' social environment

    Measured: at day 1 during the phone call

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Oct 2017
  2. Study start14 Sep 2017
  3. Primary completion15 Sep 2017
  4. Study completion15 May 2019 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Retrospective
Enrolment
660 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03309670
Sponsor's protocol ID
CHU-355
Acronym
After Pass'Aje
Status last verified
Feb 2019
First submitted
2 Oct 2017
Last updated
4 Feb 2019
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Psychiatry, run by University Hospital, Clermont-Ferrand at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 4 Feb 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Patrick LACARIN (04 73 75 11 95, placarin@chu-clermontferrand.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Psychiatric rehospitalisation (time frame: at day 1 during the phone call). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Feb 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in